(Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-Q For the quarterly period ended March 31, 2026 For the transition period from ______ to ______ Commission file number 001-41614 MINERALYS THERAPEUTICS, INC. 150 N. Radnor Chester Road, Suite F200, Radnor, PA 19087 (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization ...